Stem Cell Advances
The Scripps Research Institute (TSRI) and Fate Therapeutics have cut the time it takes to generate human induced-pluripotent stem cells (iPSCs) in half and have made the cell production process 200 times more efficient. The advance was published in Nature Methods.
At the annual American Society for Human Genetics meeting in late October, several advances in genetics were announced. RainDance has extended the capabilities of its Sequence Enrichment Solution. Illumina launched cBot, a plug and play workflow automation system for next-gen sequencing. Penn State researchers announced the first data from sequencing the Kalahari Bushmen, maybe the oldest human ethnic groups in the world. Marco Marra of British Columbia Cancer Agency in Vancouver, Canada, presented whole transcriptome shotgun sequencing results for Diffuse Large B-Cell Lymphoma pinpointing two genes.
Recovery Act Funding
The National Human Genome Research Institute has awarded more than $113 million provided by the American Recovery and Reinvestment Act. NHGRI directed its share of Recovery Act funds to more than a dozen areas of genomic research hoping to accelerate the development of innovative technologies that can efficiently sequence an entire human genome for $1,000 or less; boost insights into the organization and function of the human genome; and promote the use of newer sequencing approaches to identify and understand the genetic roots of a number of diseases. Award recipients include individuals at University of California Santa Cruz, Harvard, Stanford, Arizona State University, Helicos Biosciences, and Pacific Biosciences.